A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy

Clinical trial NCT07592910 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07592910
Sponsor: Prostate Cancer Clinical Trials Consortium
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Castrate Resistant Prostate Cancer (mCRPC)Prostate Cancer (Adenocarcinoma)

Start date: 2026-08-01
Primary completion: 2029-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.